$LNG Balance Sheet | Understand Stock

$LNG

$300.59 +$1.92 (0.64%) Close

$LNG Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
Current assets
Cash and cash equivalents
Restricted cash
Restricted cash and cash equivalents
Trade and other receivables, net of current expected credit losses
Inventory
Current derivative assets
Margin deposits
Contract assets
Prepaid expenses
Other current assets, net
Total current assets

Property, plant and equipment, net of accumulated depreciation
Operating lease assets
Deferred NPNS assets
Derivative assets
Goodwill
Deferred tax assets
Other non-current assets, net
Total assets
Current liabilities
Accounts payable
Accrued liabilities
Current debt, net of unamortized discount and debt issuance costs
Deferred revenue
Current operating lease liabilities
Current portion of deferred NPNS liabilities
Current derivative liabilities
Other current liabilities
Total current liabilities
Long-term debt, net of unamortized discount and debt issuance costs
Non-current operating lease liabilities
Finance lease liabilities
Deferred NPNS liabilities
Derivative liabilities
Deferred tax liabilities
Other non-current liabilities
Total liabilities
Redeemable NCI
Stockholders’ equity
Preferred stock: $0.0001 par value, 5.0 million shares authorized, none issued
Common stock: $0.003 par value, 480.0 million shares authorized; 279.6 million shares and 279.2 million shares issued at June 30, 2026 and December 31, 2025, respectively
Treasury stock: 71.7 million shares and 66.8 million shares at June 30, 2026 and December 31, 2025, respectively, at cost
Additional paid-in-capital
Retained earnings
Total Cheniere stockholders’ equity
NCI
Total stockholders’ equity
Total liabilities, redeemable NCI and stockholders’ equity

Comments